Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News SCCT 2025

Air Pollution in Canada Ups CAC, Total Plaque, and Obstructive CAD

Yael L. Maxwell

July 25, 2025

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Yael L. Maxwell

March 28, 2022

News Daily News

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

Michael O'Riordan

May 12, 2021

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Caitlin E. Cox

September 20, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Daily News

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Caitlin E. Cox

October 18, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Conference News ESC 2016

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Michael O'Riordan

August 31, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

Advertisement

Air Pollution in Canada Ups CAC, Total Plaque, and Obstructive CAD

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Top Coronary Artery Disease News of 2022

September 2022 News Roundup

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content